Take Solutions Profit & Loss Annual

Trade
BSE: 532890 | NSE: TAKE | ISIN: INE142I01023 | Sector: Biotechnology & Drugs
16.51 -0.18 (-1.08%)Updated : 25 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 65.61189.07652.65774.02
Total Revenue 65.61189.07652.65774.02
Costof Revenue Total 24.4483.01192.85188.08
Gross Profit 41.17106.06459.79585.94
Selling/ General/ Admin Expenses Total 14.95123.31446.03638.63
Depreciation/ Amortization 7.8816.8475.63115.38
Unusual Expense( Income) 93.1810.390.00225.07
Other Operating Expenses Total 39.691.623.6614.16
Total Operating Expense 180.14235.18718.171,181.31
Operating Income -114.53-46.11-65.52-407.30
Interest Inc( Exp) Net- Non- Op Total -54.31-6.92-195.51-341.44
Other Net 1.571.297.072.62
Net Income Before Taxes -118.39-45.27-78.01-438.80
Provisionfor Income Taxes 1.231.684.8513.55
Net Income After Taxes -119.62-46.95-82.85-452.35
Minority Interest 0.000.090.04-1.08
Net Income Before Extra Items -119.62-46.86-82.81-453.43
Total Extraordinary Items 0.00-53.40-699.441.40
Net Income -119.62-100.27-782.25-452.03
Income Availableto Com Excl Extra Ord -119.62-46.86-82.81-453.42
Income Availableto Com Incl Extra Ord -119.62-100.27-782.25-452.02
Diluted Net Income -119.62-100.27-782.25-452.02
Diluted Weighted Average Shares 14.6214.6214.6214.62
Diluted EPS Excluding Extra Ord Items -8.18-3.20-5.66-31.01
Diluted Normalized EPS -4.04-2.75-5.66-21.01
Gain( Loss)on Saleof Assets -2.340.010.28
Total Adjustmentsto Net Income ---0.01
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts